IP Library Granted Patent US 11,648,123
Granted Patent B1
US 11,648,123 · App. 17/951,787 · Granted May 16, 2023

Interbody spacer for spinal fusion

Inventor: Josh Arnone (St. Charles, MO)
Assignee: CORELINK, LLC
A61F2/30767A61F2/30771A61F2/30907A61F2/447A61F2/4455A61F2/4465A61F2002/2835A61F2002/30011A61F2002/3092A61F2002/3093A61F2002/30774A61F2002/30904A61F2002/30968A61F2002/30978A61F2002/30985A61F2002/4629
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,648,123
App. No.
17/951,787
Granted
May 16, 2023
Kind
B1
Abstract

An interbody spacer for spinal fusion surgery includes first and second opposite side walls that have open-cell metal foam at upper and lower faces, and a three-dimensional lattice disposed between open-cell metal foam at the upper and lower faces. The open-cell metal foam is in communication with the three-dimensional lattice so that bone growth can enter the three-dimensional lattice from the open-cell metal foam. The interbody spacer may be formed by additive manufacturing.

Claims (28)

1. An interbody spacer for an orthopedic surgical procedure, the interbody spacer comprising:

first and second opposing walls each having upper and lower portions; and

open-cell metal foam at the upper and lower portions of the first and second opposing walls, wherein the open-cell metal foam at least partially defines upper and lower faces of the interbody spacer,

wherein each of the first and second opposing walls includes a lattice comprising a non-randomized arrangement of struts defining a plurality of transverse openings.

2. The interbody spacer set forth in claim 1 , wherein the open-cell metal foam comprises titanium.

3. The interbody spacer set forth in claim 2 , wherein the first and second opposing walls comprise titanium.

4. The interbody spacer set forth in claim 3 , wherein the interbody spacer is formed as a one-piece, monolithic component.

5. The interbody spacer set forth in claim 4 , wherein the interbody spacer is formed by additive manufacturing.

6. The interbody spacer set forth in claim 1 , wherein the transverse openings have cross-sectional shapes defining a pattern.

7. The interbody spacer set forth in claim 6 , wherein the cross-sectional shapes of the transverse openings include diamond shapes.

8. The interbody spacer set forth in claim 6 , wherein the cross-sectional shapes of the transverse openings include oval shapes.

9. The interbody spacer set forth in claim 1 , further comprising an interior cavity extending through the upper and lower faces of the interbody spacer and between the first and second opposing walls.

10. The interbody spacer set forth in claim 9 , wherein each of the first and second opposing walls has interior and exterior surfaces, wherein the transverse openings extend through the exterior surfaces of the first and second opposing walls and toward the interior cavity.

11. The interbody spacer set forth in claim 9 , further comprising open-cell metal foam in the interior cavity.

12. The interbody spacer set forth in claim 1 , wherein the open-cell metal foam is in communication with the transverse openings.

13. An interbody spacer for an orthopedic surgical procedure, the interbody spacer comprising:

first and second opposing walls each having upper and lower portions;

open-cell metal foam at the upper and lower portions of the first and second opposing walls, wherein the open-cell metal foam at least partially defines upper and lower faces of the interbody spacer,

wherein each of the first and second opposing walls includes a plurality of transverse openings, the transverse openings having cross-sectional shapes defining a pattern.

14. The interbody spacer set forth in claim 13 , further including an interior cavity extending through the upper and lower faces of the interbody spacer and between the first and second opposing walls.

15. The interbody spacer set forth in claim 13 , wherein each of the first and second opposing walls has interior and exterior surfaces, wherein the transverse openings extend through the exterior surfaces of the first and second opposing walls and toward the interior cavity.

16. The interbody spacer set forth in claim 13 , wherein the open-cell metal foam is in communication with the transverse openings.

17. The interbody spacer set forth in claim 13 , wherein each of the first and second opposing walls includes a lattice comprising a non-randomized arrangement of struts defining the plurality of transverse openings.

18. An implant for an orthopedic procedure comprising:

an implant body configured to be implanted in bone of a subject; and

open-cell metal foam on the implant body,

wherein the open-cell metal foam is disposed in recessed portions of the implant body.

19. A method of forming the implant set forth in claim 1 , comprising additively manufacturing the first and second opposing walls and the open-cell metal foam as a single, monolithic one-piece component.

Assignments (3)
SECURITY INTEREST Recorded Jul 22, 2024
From: CORELINK, LLC
To: VARAGON CAPITAL PARTNERS AGENT, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 068045/0638 →
SECURITY INTEREST Recorded Jun 24, 2024
From: CORELINK, LLC
To: VARAGON CAPITAL PARTNERS AGENT, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 067820/0916 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2022
From: ARNONE, JOSH
To: CORELINK, LLC
Reel/Frame 061535/0499 →
Continuity (4)
Continuation 17664150 · May 19, 2022
Continuation 16722090 · Dec 20, 2019
Continuation 15792140 · Oct 24, 2017
Provisional Application 62412091 · Oct 24, 2016